Bonness Enterprises’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49,860
Closed -$866K 40
2023
Q3
$866K Hold
49,860
0.4% 38
2023
Q2
$1.04M Sell
49,860
-2,090
-4% -$45.4K 0.47% 35
2023
Q1
$1.22M Hold
51,950
0.54% 33
2022
Q4
$1.45M Hold
51,950
0.68% 34
2022
Q3
$1.22M Hold
51,950
0.65% 33
2022
Q2
$1.75M Hold
51,950
0.88% 31
2022
Q1
$1.81M Hold
51,950
0.83% 31
2021
Q4
$1.58M Buy
51,950
+45,200
+670% +$1.47M 0.73% 33
2021
Q3
$221K Sell
6,750
-200
-3% -$6.4K 0.11% 40
2021
Q2
$210K Buy
+6,950
New +$229K 0.11% 40

Other funds holding OGN

Bonness Enterprises's OGN Position: Q4 2023 in Review

Bonness Enterprises sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 49,860 shares — an estimated $866K sold.

Bonness Enterprises first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.81M in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Bonness Enterprises reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Bonness Enterprises sold 49,860 Organon & Co shares in Q4 2023, an estimated $866K.
  • Bonness Enterprises first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Bonness Enterprises's Organon & Co position peaked at $1.81M in Q1 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Bonness Enterprises's 13F filing for Q4 2023, filed 22 Jan 2024.